Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

Name: Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

infections

infections, cytomegalovirus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 283097
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.